Urinary Hyaluronan as a Marker for the Presence of Residual Transitional Cell Carcinoma of the Urinary Bladder
Authors:
- Carlo C. PasserottiCPCarlo C. Passerotti
- Alexandre BonfimABAlexandre Bonfim
- João R.M. MartinsJMJoão R.M. Martins
- Marcos F. Dall’oGlioMDMarcos F. Dall’oGlio
- Lucia O. SampaioLSLucia O. Sampaio
- Aline MendesAMAline Mendes
- Valdemar OrtizVOValdemar Ortiz
- Miguel SrougiMSMiguel Srougi
- Carl P. DietrichCDCarl P. Dietrich
- Helena B. NaderHNHelena B. Nader
- 1 January 2006
- journal article
- Published by Elsevier in European Urology
- Vol. 49 (1) , 71-75
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- A SIDE BY SIDE COMPARISON OF CYTOLOGY AND BIOMARKERS FOR BLADDER CANCER DETECTIONJournal of Urology, 2004
- A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?European Urology, 2004
- Second Transurethral Resection of Superficial Transitional Cell Carcinoma of the Bladder: A Must Even for Experienced UrologistsUrologia Internationalis, 2004
- Current bladder cancer tests: unnecessary or beneficial?Critical Reviews in Oncology/Hematology, 2003
- Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat testsCancer, 2002
- ELEVATED TISSUE EXPRESSION OF HYALURONIC ACID AND HYALURONIDASE VALIDATES THE HA-HAase URINE TEST FOR BLADDER CANCERJournal of Urology, 2001
- CURRENT BLADDER TUMOR TESTS: DOES THEIR PROJECTED UTILITY FULFILL CLINICAL NECESSITY?Journal of Urology, 2001
- THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORSJournal of Urology, 1999
- Serum Hyaluronan as a Disease MarkerAnnals of Medicine, 1996